Current concepts in antibiotic-resistant gram-negative bacteria (Q36960068)

17 August 2017

1 reference

title

Current concepts in antibiotic-resistant gram-negative bacteria (English)

1 reference

17 August 2017

Gram-negative bacteria

0 references

author name string

Julián Andrés Torres

series ordinal

1

1 reference

PubMed ID

17914917

17 August 2017

Maria Virginia Villegas

series ordinal

2

1 reference

PubMed ID

17914917

17 August 2017

John P Quinn

series ordinal

3

1 reference

17 August 2017

1 October 2007

1 reference

Expert Review of Anti-infective Therapy

17 August 2017

1 reference

17 August 2017

5

1 reference

17 August 2017

5

1 reference

17 August 2017

833-843

1 reference

Resistance patterns among nosocomial pathogens: trends over the past few years

17 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

The threat from the pink corner

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a five-year summary from the SENTRY Antimicrobial Surveillance Program (1997-2001).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other gram-negative bacteria. Insights from the Society of Infectious Diseases Pharmacists

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Plasmid-determined AmpC-type beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

21 January 2018

The new beta-lactamases.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Extended-spectrum beta-lactamases: a clinical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

CTX-M: changing the face of ESBLs in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Emerging carbapenemases in Gram-negative aerobes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Escherichia coli: development of carbapenem resistance during therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Dissemination of Acinetobacter baumannii clones with OXA-23 Carbapenemase in Colombian hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Long-term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

First report of the carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter baumannii isolates in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Metallo-beta-lactamases: the quiet before the storm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

First outbreak of multidrug-resistant Klebsiella pneumoniae carrying blaVIM-1 and blaSHV-5 in a French university hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Metallo-beta-lactamase-producing Enterobacteriaceae isolates in a university hospital in Taiwan: prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Acquired carbapenem-hydrolyzing beta-lactamases and their genetic support

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

First detection of metallo-beta-lactamase VIM-2 in Pseudomonas aeruginosa isolates from Colombia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

The aminoglycoside 6'-N-acetyltransferase type Ib encoded by Tn1331 is evenly distributed within the cell's cytoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Modes and modulations of antibiotic resistance gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Outer membranes and efflux: the path to multidrug resistance in Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

SmeC, an outer membrane multidrug efflux protein of Stenotrophomonas maltophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Molecular and structural characterization of the HMP-AB gene encoding a pore-forming protein from a clinical isolate of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Molecular basis of bacterial outer membrane permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Cloning and functional analysis of the gene encoding the 33- to 36-kilodalton outer membrane protein associated with carbapenem resistance in Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Channel formation by CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Identification of an OprD homologue in Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Resistance to beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Quinolone resistance from a transferable plasmid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Plasmid-mediated quinolone resistance in isolates obtained in german intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Prevalence and genetic analysis of plasmid-mediated quinolone resistance determinants QnrA and QnrS in Enterobacteriaceae isolates from a French university hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Broader distribution of plasmid-mediated quinolone resistance in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Trends in antimicrobial drug development: implications for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Properties and potential of ertapenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with beta-lactam antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.833

21 January 2018

Identifiers

DOI

10.1586/14787210.5.5.833

1 reference

17 August 2017

1 reference

PubMed ID

17914917